This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cutaneous manifestations of monoclonal gammopathy
Blood Cancer Journal Open Access 11 April 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sykes DB, Schroyens W, O'Connell C . The TEMPI syndrome—a novel multisystem disease. N Engl J Med 2011; 365: 475–477.
Jasim S, Mahmud G, Bastani B, Fesler M . Subcutaneous bortezomib for treatment of TEMPI syndrome. Clin Lymphoma Myeloma Leuk 2014; 14: e221–e223.
Kwok M, Korde N, Landgren O . Bortezomib to treat the TEMPI syndrome. N Engl J Med 2012; 366: 1843–1845.
Rosado FG, Oliveira JL, Sohani AR, Schroyens W, Sykes DB, Kenderian SS et al. Bone marrow findings of the newly described TEMPI syndrome: when erythrocytosis and plasma cell dyscrasia coexist. Mod Pathol 2015; 28: 367–372.
Schroyens W, O'Connell C, Sykes DB . Complete and partial responses of the TEMPI syndrome to bortezomib. N Engl J Med 2012; 367: 778–780.
Viglietti D, Sverzut JM, Peraldi MN . Perirenal fluid collections and monoclonal gammopathy. Nephrol Dial Transplant 2012; 27: 448–449.
Dispenzieri A . POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011; 86: 591–601.
Jain T, Offord CP, Kyle RA, Dingli D . Schnitzler syndrome: an under-diagnosed clinical entity. Haematologica 2013; 98: 1581–1585.
Lacy MQ, Hogan WJ, Gertz MA, Dispenzieri A, Rajkumar SV, Hayman S et al. Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation. Arch Dermatol 2005; 141: 1277–1282.
Dispenzieri A, Seenithamby K, Lacy MQ, Kumar SK, Buadi FK, Hayman SR et al. Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center. Bone Marrow Transplant 2013; 48: 1302–1307.
D'Souza A, Lacy M, Gertz M, Kumar S, Buadi F, Hayman S et al. Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood 2012; 120: 56–62.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kenderian, S., Rosado, F., Sykes, D. et al. Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation. Leukemia 29, 2414–2416 (2015). https://doi.org/10.1038/leu.2015.298
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.298
This article is cited by
-
Cutaneous manifestations of monoclonal gammopathy
Blood Cancer Journal (2022)
-
Relapsed multiple myeloma as TEMPI syndrome with good response to salvage lenalidomide and dexamethasone
Annals of Hematology (2019)